RECENT NEWS
June 14, 2010 AGILE THERAPEUTICS SECURES $45M IN SERIES B FUNDING TO PROGRESS LEAD CONTRACEPTIVE PATCH, AG200-15, THROUGH NDA FILING October 15, 2009Frost & Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low-Dose Contraceptive Patch March 26, 2009 NICHD/NIH TO CONDUCT CLINICAL STUDY WITH AGILE'S WEEKLY, PROGESTIN-ONLY, CONTRACEPTIVE PATCH Agile Therapeutics and NICHD Collaboration Intended to Provide Breast Feeding Mothers with Needed Contraceptive Option
